John O. Link

Electrochemiluminescence detection for development of immunoassays and DNA probe assays for clinical diagnostics

Gary F. Blackburn, Haresh P. Shah, John H. Kenten et al. · Clinical Chemistry · 1991 · 551 citations

Clinical targeting of HIV capsid protein with a long-acting small molecule

John O. Link, Martin S. Rhee, Winston C. Tse et al. · Nature · 2020 · 392 citations · Full text

Natural Sciences, Human Retrovirus, Immunology +10

Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection

John O. Link, James G. Taylor, Lianhong Xu et al. · Journal of Medicinal Chemistry · 2013 · 290 citations

A general, catalytic, and enantioselective synthesis of .alpha.-amino acids

E. J. Corey, John O. Link · Journal of the American Chemical Society · 1992 · 255 citations

.Alpha.-amino Acids, Engineering, Biochemistry +11

A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C

Eric Lawitz, Daniel Gruener, John M. Hill et al. · Journal of Hepatology · 2012 · 158 citations

Hepatology, Hepatitis C, Medicine +8